Kinnate Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Mar 22 | BuyUS$338,850 | Richard Williams | Individual | 40,000 | US$8.64 | |
15 Feb 22 | BuyUS$1,989,446 | OrbiMed Advisors LLC | Company | 195,700 | US$10.22 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 123,361 | 0.3% |
Hedge Funds | 2,213,178 | 5.0% |
Institutions | 20,153,455 | 45.5% |
VC/PE Firms | 21,807,972 | 49.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
10,838,311 | $86.5m | 0% | 12.68% | |||
4,264,144 | $34.0m | 0% | 0.55% | |||
4,043,629 | $32.3m | 0% | 0.44% | |||
2,661,888 | $21.2m | -11.51% | 7.33% | |||
2,430,102 | $19.4m | 10.8% | no data | |||
2,276,816 | $18.2m | -0.99% | no data | |||
2,213,178 | $17.7m | 32.16% | 11.01% | |||
2,207,772 | $17.6m | -19.64% | 10.18% | |||
1,820,462 | $14.5m | 0% | 0.05% | |||
1,522,559 | $12.2m | -17.59% | 0.52% | |||
1,212,611 | $9.7m | 0% | 0.18% | |||
1,096,301 | $8.7m | -2.76% | 0.01% | |||
1,011,347 | $8.1m | 1.53% | no data | |||
815,707 | $6.5m | 0% | 0.01% | |||
746,973 | $6.0m | 20.79% | 0.13% | |||
524,669 | $4.2m | 101.58% | 0.05% | |||
498,001 | $4.0m | 0% | 0.4% | |||
466,521 | $3.7m | 3.15% | no data | |||
420,709 | $3.4m | 2.49% | no data | |||
321,834 | $2.6m | 0.59% | no data | |||
307,800 | $2.5m | 0% | 0.01% | |||
250,000 | $2.0m | 0% | 0.05% | |||
220,624 | $1.8m | -2.21% | no data | |||
175,000 | $1.4m | 0% | 0.04% | |||
152,589 | $1.2m | -9.36% | no data |